Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Is space worth the cost? Accounting experts say its value can’t be found in spreadsheets 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission 
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint 
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 
Intermittent fasting doesn’t have an edge for weight loss, but might still work for some 
Astronomers have discovered another puzzling interstellar object − this third one is big, bright and fast 
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil 
The four types of dementia most people don’t know exist 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 
Although plenty of advancements in medical science have allowed humans to reduce the health impact of diabetes, a cure is still far off in the distance. With the advent of CRISPR, however, researchers are now much closer to finding effective treatment methods that will completely cure diabetics. These include stem cell implants and skin grafts.
One of the biggest challenges to combating both type-1 and type-2 diabetes is the matter of insulin production. Once those sensors in the body get broken, either not enough insulin is produced or the hormone itself becomes difficult for the body to process, Futurism reports. Thanks to certain advancements in gene-editing, however, these may not be much of a problem in the future.
On one hand, there’s the stem cell-based PEC-Direct implant that is made by the company ViaCyte. Similar in size to credit cards, these implants are basically meant to supplement the pancreas cells that the immune system has destroyed in type-1 patients. As the implants mature, they release insulin as needed, which would remove the necessity of injecting the hormone into the body.
The other method is a skin graft that was developed by researchers at the University of Chicago. Created using CRISPR, the scientists were able to create an artificial layer of skin that would promote insulin release, which would then manage the symptoms of diabetes. This particular method is initially intended for type-2 cases, but its scope can go beyond the disease.
Using the skin graft on lab mice, the researchers noticed marked improvements regarding symptoms associated with diabetes. Human trials are not on the table yet, however.
According to the researchers that worked on the study, it could also be applied to other kinds of metabolic conditions and genetic diseases that are caused by issues related to hormone production. It’s worth noting that, while this is not exactly curing diabetes, it does help improve the understanding of scientists when it comes to the potential solutions regarding skin graft.
